Crossmark

Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?

Crossref DOI link: https://doi.org/10.1007/s40265-018-0915-5

Published Online: 2018-05-08

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Weisshaar, Stefan

Zeitlinger, Markus
License Information

Text and Data Mining valid from 2018-05-08
More Information

Article History

First Online: 8 May 2018

Compliance with ethical standards

:

: No external funding was used in the preparation of this manuscript.

: Stefan Weisshaar and Markus Zeitlinger declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.